EU to Review Felodipine
The European Medicines Evaluation Agency announced on Friday a review of the calcium channel blocker felodipine because
The European Medicines Evaluation Agency announced on Friday a review of the calcium channel blocker felodipine because
The risk of cardiovascular disease in patients with type II diabetes may be some 30% higher than
Long-term treatment with the ACE inhibitor lisinopril improves myocardial perfusion reserve (MPR) and maximal coronary flow in
Reducing patient dietary sodium intake has little effect or either cardiovascular events or mortality. There also are
Waist circumference is a better indicator of cardiovascular (CV) riskthan is body mass index (BMI), according to
For patients older than 80 years of age, off-pump coronary artery bypass surgery is associated with reduced
Patients with end-stage heart failure benefit from resynchronization therapy with improved symptoms, quality-of-life, exercise endurance and left
Laurie Barclay, MD Sept. 16, 2002 Nocturnal blood pressure may be the best early indicator of
Laurie Barclay, MD Sept. 18, 2002 Editor’s Note: New guidelines for diet and exercise issued earlier
Losartan significantly reduces the risk of stroke in hypertensive patients with atrial fibrillation and left ventricular hypertrophy
נא ציין כתובת דואר אלקטרוני שבה אתה מקבל דיוורי e-Med או זו שציינת בכרטיס האישי שלך.
קישור לאיפוס סיסמא נשלח למייל.
חזרה להתחברות